Compounds which inhibit human conjunctival mast cell degranulation for treating ocular allergic-type complications
US6225327A · kind A · utility
19Cited by
3References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 7, 1998 |
| Grant date | May 1, 2001 |
| Priority date | — |
| Expiry date | Oct 7, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4439
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Composition and methods for treating ocular allergic reactions are disclosed. In particular, the invention is directed to compounds which inhibit human conjunctival mast cell degranulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.